These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16612063)

  • 61. Prenatal diagnosis of sickle cell anemia and beta-thalassemia in southern Turkey.
    Cürük MA; Zeren F; Genç A; Ozavci-Aygün S; Kilinç Y; Aksoy K
    Hemoglobin; 2008; 32(6):525-30. PubMed ID: 19065329
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007.
    Yilmaz GR; Buzgan T; Irmak H; Safran A; Uzun R; Cevik MA; Torunoglu MA
    Int J Infect Dis; 2009 May; 13(3):380-6. PubMed ID: 18986819
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Study of hemoglobinopathy in Kashi district of Xinjiang].
    Yu W; Zhang Z; Li H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Apr; 19(4):198-200. PubMed ID: 11243136
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Searching for consensus through multi-criteria decision analysis. Assessment of screening strategies for hemoglobinopathies in southeastern France.
    Le Gales C; Moatti JP
    Int J Technol Assess Health Care; 1990; 6(3):430-49. PubMed ID: 2228458
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hemoglobinopathy screening in primary care in the Netherlands: exploring the problems and needs of patients and general practitioners.
    van Vliet ME; Kerkhoffs JH; Harteveld CL; Houwink EJF
    Eur J Hum Genet; 2023 Apr; 31(4):417-423. PubMed ID: 35945245
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Providing appropriate genetic information to healthy carriers of hemoglobinopathy can be a welcome and safe initiative: the Latium example.
    Amato A; Lerone M; Grisanti P; Gizzi L; Kaufmann JO; Giordano PC
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):734-8. PubMed ID: 22731645
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Iowa Newborn Screening Program Experience with Hemoglobinopathy Screening over the Last Two Decades and Its Increasing Global Relevance.
    Jilek R; Marcy J; Johnson C; Younger G; Calhoun A; Tung ML
    Int J Neonatal Screen; 2024 Mar; 10(1):. PubMed ID: 38535125
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A new donor system for the patients with thalassemia: "Blood mother and blood father".
    Canatan D; Ozsancak A
    Asian J Transfus Sci; 2010 Jul; 4(2):109-11. PubMed ID: 20859510
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Current and potential options for preventing hemoglobinopathies.
    Headings VE; Scott RB
    South Med J; 1975 Nov; 68(11):1429-32. PubMed ID: 1188432
    [No Abstract]   [Full Text] [Related]  

  • 70. Spectrum of Hemoglobinopathies: A New Revelation in a Tertiary Care Hospital of Odisha.
    Ray GK; Jena RK
    Indian J Hematol Blood Transfus; 2019 Jul; 35(3):513-517. PubMed ID: 31388266
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hemoglobin H Disease in Turkey: Experience from Eight Centers.
    Ünal S; Oktay G; Acıpayam C; İlhan G; Gali E; Celkan T; Bay A; Malbora B; Akar N; Oymak Y; Toptaş T
    Turk J Haematol; 2016 Mar; 33(1):56-9. PubMed ID: 26376738
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [A comprehensive repository of mutation data and a clinical assistant decision system for hemoglobinopathy in the Chinese population].
    Zhang QQ; Zhang L; Tang YH; Li XR; Xu XP; Qi M; Xu XM
    Yi Chuan; 2019 Aug; 41(8):746-753. PubMed ID: 31447425
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Routine screening for hemoglobinopathy in blacks.
    Miller JM; Davis DC
    Md State Med J; 1979 Mar; 28(3):35. PubMed ID: 431140
    [No Abstract]   [Full Text] [Related]  

  • 74. A Further Note on the Thalassemia Screening Program in the Muğla Region of Turkey.
    Akar N
    Hemoglobin; 2016; 40(1):74. PubMed ID: 26574929
    [No Abstract]   [Full Text] [Related]  

  • 75. [Symposium on genetics in internal medicine. Hemoglobinopathy, with special reference to Hb M disease].
    Shibata S
    Nihon Naika Gakkai Zasshi; 1968 Dec; 57(12):1465-6. PubMed ID: 5752563
    [No Abstract]   [Full Text] [Related]  

  • 76. Targeting ZNF410 as a potential β-hemoglobinopathy therapy.
    Tumburu L; Thein SL
    Nat Genet; 2021 May; 53(5):589-590. PubMed ID: 33859418
    [TBL] [Abstract][Full Text] [Related]  

  • 77. European migration crises: The role of national hemoglobinopathy registries in improving patient access to care.
    Inusa BPD; Colombatti R
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28371007
    [No Abstract]   [Full Text] [Related]  

  • 78. The Impact of Sample Degradation on Hemoglobinopathy Investigations: A Cautionary Tale.
    Agbor TA; Bordeleau P; Kyle B; Parker ML; Estey MP
    J Appl Lab Med; 2021 Apr; 6(3):804-807. PubMed ID: 33169140
    [No Abstract]   [Full Text] [Related]  

  • 79. Compound Heterozygous Hemoglobinopathy Complicated by Inaccurate Capillary Electrophoresis Zoning.
    Mallika Krishnan S; Gherasim C; Li SH; Manthei DM
    Clin Chem; 2023 Sep; 69(9):961-965. PubMed ID: 37654068
    [No Abstract]   [Full Text] [Related]  

  • 80. Commentary on Compound Heterozygous Hemoglobinopathy Complicated by Inaccurate Capillary Electrophoresis Zoning.
    Miller SP
    Clin Chem; 2023 Sep; 69(9):965. PubMed ID: 37654066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.